Evidence map›Paper›PMID 35409851›Full record

ArticleInternational journal of environmental research and public health2022

Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.

Dorota Kopciuch, Nashwa Nabil Kamal, Nashaat Nabil Kamal, Nermin Aly Hamdy, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Jędrzej Fliciński, Krzysztof Kus, Elżbieta Nowakowska

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Spontaneous adverse drug reaction reporting: potential facilitators perceived by community pharmacists in Egypt - a cross-sectional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Dorota KopciuchDepartment of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-6547-6112
Nashwa Nabil KamalDepartment of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia 61-511, Egypt.
Nashaat Nabil KamalDepartment of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia 61-511, Egypt.
Nermin Aly HamdyDepartment of Neurology and Psychiatry, Minia University, Minya 61-511, Egypt.
Anna PaczkowskaDepartment of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0002-0058-2632
Tomasz ZaprutkoDepartment of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-9737-9624
Piotr RatajczakDepartment of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-9118-2222
Jędrzej FlicińskiDepartment of Developmental Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Krzysztof KusDepartment of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Elżbieta NowakowskaDepartment of Pharmacology and Toxicology Institute of Health Sciences, Collegium Medicum, University of Zielona Gora, 65-417 Zielona Góra, Poland.
Poznan University of Medical Sciences · PLMisr University for Science and Technology · EGMinia University · EGUniversity of Zielona Góra · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare neurologists' knowledge, practice, and barriers of pharmacovigilance (PV) process among patients with epilepsy in Poland and Egypt.

methodsIt was an international study that used an online questionnaire e-mailed to neurologists registered to practice in Poland and Egypt.

resultsMost of the neurologists were familiar with the definition of PV and adverse drug reactions (ADRs), but relatively few neurologists knew where to report ADRs, especially the Egyptian neurologists. Only 31.11% of the neurologists from Egypt and 39.90% neurologists from Poland declared that they had reported ADRs at least once during their professional practice, and few of them declared the regular reporting of such incidents. The main reason for the neurologists not reporting ADRs was the lack of time and a conviction that reporting ADRs would be an additional burden that would generate extra work.

conclusionThe standards of pharmacovigilance process, safety control, and quality are not the same throughout the world. System-regulated PV stabilization in a country translates into the practice of maintaining PV. Monitoring the safety of pharmacotherapy and knowledge of risks associated with ADRs should be included in the academic curricula of physician courses.

Indexed as

Drug-Related Side Effects and Adverse ReactionsEpilepsyAdverse Drug Reaction Reporting SystemsCross-Sectional StudiesEgyptHealth Knowledge, Attitudes, PracticeHumansNeurologistsPharmacovigilancePolandadverse drug reactionsdrug safetyEgyptepilepsyneurologists’ knowledgepharmacovigilancePoland

Identifiers

PMID35409851
PMCPMC8998900
OpenAlexW4221121015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.